GlaxoSmithKline is looking to make further acquisitions this year but any mega-merger is looking highly unlikely, according to chief executive Andrew Witty. GlaxoSmithKline is looking to make further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results